Cipla
Tracked across 8 events · 63 articles · First seen Mar 20, 2025 · Last active Aug 20, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Cipla entered into an exclusive agreement with Pfizer India to market, distribute, and sell four of Pfizer's brands in India, expanding its presence in key therapy areas and leveraging its distribution capabilities.
Dec 19, 2025 · 6 articles
Business
Impact: Cipla reported a 39% net profit decline due to North America sales drop and higher expenses; its India business achieved record sales. The company appointed a new CFO and expects sequential recovery in North America.
Jul 23, 2026 · 6 articles
Domestic
Impact: Cipla>>> is one of the generic drugmakers in India>>> that produces platinum-based chemotherapy, and its production is affected by the platinum shortage and price caps.
Jun 09, 2026 · 9 articles
Tech
Impact: Cipla is one of the 23 leading pharmaceutical companies included in the Indian Pharmaceutical Alliance, which is a partner in the Indian AI Research Organization (IAIRO) project.
Dec 30, 2025 · 7 articles
Regulatory
Impact: Achin Gupta, MD & Global CEO of Cipla, delivered the vote of thanks at the India Pharma 2026 conference.
Apr 12, 2026 · 6 articles
Business
Impact: Eli Lilly and Company has partnered with Cipla to market Tirzepatide in India, aiming to widen its distribution.
Nov 11, 2025 · 6 articles
Business
Impact: Cipla partnered with Eli Lilly and Company to market and distribute tirzepatide in India, similar to the Novo Nordisk-Emcure Pharmaceuticals collaboration.
Nov 10, 2025 · 6 articles
Regulatory
Impact: Cipla is mentioned only as former employer of Murali Neelakantan; not directly involved.
Jul 07, 2026 · 17 articles
ERGEN INTELLIGENCE
Track Cipla live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard